The U.S. Food and Drug Administration approved Corifact, the first product intended to prevent bleeding in people with the rare genetic defect congenital Factor XIII deficiency. Patients with congenital Factor XIII deficiency don’t make enough Factor XIII, a substance that… Fonte : Salute domani Tag : Salute

Read the rest here:
Rare genetic defect congenital Factor XIII deficiency: FDA approves Corifact to prevent bleeding (Salute domani)

The U.S. Food and Drug Administration approved the Selenia Dimensions System, the first X-ray mammography device that provides three-dimensional (3-D) images of the breast for breast cancer screening and diagnosis. A mammogram is a safe, low-dose X-ray of the breast… Fonte : Salute domani Tag : Salute

Read the original:
FDA approves first 3-D mammography imaging system. Selenia Dimensions System may boost accuracy in breast cancer detection, diagnosis (Salute domani)

The U.S. Food and Drug Administration proposed the Innovation Pathway, a priority review program for new, breakthrough medical devices and announced the first submission: a brain-controlled, upper-extremity prosthetic that will serve as a pilot for the program. The FDA also… Fonte : Salute domani Tag : Salute

Excerpt from:
FDA launches Medical Device Innovation Initiative (Salute domani)

A new mobile radiology application cleared today by the U.S. Food and Drug Administration will allow physicians to view medical images on the iPhone and iPad manufactured by Apple Inc. The application is the first cleared by the FDA for… Fonte : Salute domani Tag : Salute

See the original post here:
FDA clears first diagnostic radiology application for mobile devices (Salute domani)

Bayer HealthCare and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced positive top-line results for VEGF Trap-Eye (aflibercept ophthalmic solution) in the COPERNICUS study, which is led by Regeneron, the first of two Phase 3 studies in patients with macular edema due… Fonte : Salute domani Tag : Salute

Read the original here:
VEGF Trap-Eye in Central Retinal Vein Occlusion and in Diabetic Macular Edema (Salute domani)

Bayer HealthCare and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced positive top-line results for VEGF Trap-Eye (aflibercept ophthalmic solution) in the COPERNICUS study, which is led by Regeneron, the first of two Phase 3 studies in patients with macular edema due… Fonte : Salute domani Tag : Salute

The rest is here:
VEGF Trap-Eye in Central Retinal Vein Occlusion and in Diabetic Macular Edema (Salute domani)

If a woman doesn’t get enough of the B vitamin folic acid, her baby could have severe – even fatal – birth defects of the brain or spine. But these neural tube defects develop in the first weeks of pregnancy… Fonte : Salute domani Tag : Salute

Continue reading here:
B vitamin folic acid for baby (Salute domani)

About 100 years ago, the first case of what’s now called sickle cell disease was documented. More than 100,000 people in the United States have the inherited blood disorder, which can lead to infection, anemia, extreme pain, stroke, asthma and… Fonte : Salute domani Tag : Salute

Here is the original post:
A century of sickle cell (Salute domani)